Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05646459Phase 1Withdrawn
Phase 1, randomised trial of cannabidiol in periodontitis (3 arms), sponsored by University of Nebraska. Primary endpoint: Clinical Attachment Level at 6 months. Planned start May 2020; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05646459.